RT Journal Article
SR Electronic
T1 015 How  can we prevent overdoses and what works? a systematic review of interventions for non fatal poisonings
JF Emergency Medicine Journal
JO Emerg Med J
FD BMJ Publishing Group Ltd and the British Association for Accident & Emergency Medicine
SP e1
OP e1
DO 10.1136/emj.2010.108605.15
VO 28
IS 3
A1 Helen Snooks
A1 Daphne Russell
A1 Christine Brown
A1 Akshey Nair
A1 Chris Moore
A1 Alan Lewis
A1 Gareth Thomas
A1 Mohammed al-Sulaiti
A1 Marie Thomas
A1 Faye Griffith-Noble
YR 2011
UL http://emj.bmj.com/content/28/3/e1.7.abstract
AB Background Deaths from opiate overdose in the UK are among the highest in Europe. Drug related deaths in Wales are not reducing. Naloxone is administered to reverse overdose by paramedics and in emergency departments.Aim To describe interventions to treat overdoses in the pre-hospital setting and review their effectiveness.Method 1—systematic literature search; 2—selection of comparative studies for qualitative synthesis; 3—meta-analysis of suitable studies.Results 39 references described interventions in six categories: 1) take-home naloxone administered by peers to an overdose patient, following training; 2) CPR training for bystanders witnessing an overdose; 3) routes of naloxone administration by health professionals; 4) police attendance protocols to encourage 999 calls by peers witnessing an overdose; 5) supervised injection facilities; 6) psychosocial/educational interventions. Fifteen studies were included in the systematic review. Populations, interventions, methods and outcome were heterogeneous. Evidence of effectiveness was weak but suggested death rates may be reduced by: take-home naloxone; bystander CPR; treatment for addiction; naloxone implants. Many studies were of poor quality. Inter-study results were not comparable. Meta-analysis of effectiveness was not possible.Discussion Naloxone is an effective treatment for the reversal of opiate overdose. Yet there is little evidence of effectiveness for interventions identified in this review, including issuing trained drug users with naloxone to treat peers. Roll out of take-home naloxone in Wales should be rigorously evaluated to assess clinical and cost effectiveness, adverse event rates and effects on drug-taking behaviour.